AzTrials
AzTrials

Endocrine DisruptorsPERTHNCT06571994

The Plastic Exposure Reduction Transforms Health Trial

A study testing Low Plastic Intervention in people with Endocrine Disruptors and Inflammation, run by The University of Western Australia at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
Low Plastic Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteAustralia
Study dates
5 Sep 2024to 4 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Biological males or, non-pregnant, non-lactating biological females aged 18 to 60 years.
  • For female participants at least one of the following must apply: i) Not of childbearing potential - surgical sterile or postmenopausal (no menses last 12 months and follicle-stimulating hormone (FSH) greater than 40 mIU/mL); ii) Childbearing potential and agrees to practice true abstinence, is in a same-sex relationship or agrees to use effective contraception during the study (either hormonal contraception, intrauterine devices or condom) or has a vasectomised male partner.
  • Body mass index ≥30 kg/m2. If outside this range, eligible at investigator's discretion.
  • Waist circumference ≥102cm in men and ≥88cm in women. If outside this range, eligible at investigator's discretion.
  • Certain medications may be excluded based on investigators discretion.
  • Lives in the Perth Metropolitan Area.
Show all 9Show fewer
  • Willing to change all they eat, not eat out and not wear makeup for 4 weeks if selected for intervention.
  • Ability to give written informed consent.
  • Proof of immunisation against COVID-19 (SARS-CoV-2), according to WA Health guidelines at time of recruitment.

Who cannot join

  • Any abnormalities in electrocardiogram (ECG) readings, or as per the Investigator's discretion.
  • History of drug or alcohol abuse in the past 24 months. Alcohol abuse defined as greater than 21 units/week for males, greater than 14 units/week for females.
  • Current regular smoker or e-cigarette use. Social smokers (less than 3 nicotine/tobacco products in the last 3 months) can be included if abstaining for the duration of the study.
  • Currently pregnant or planning pregnancy during the course of the study as assessed by pregnancy testing carried out during screening.
  • Currently on, or within 3 months of discontinuing, glucagon-like peptide-1 agonists or related compounds. If inside this range, eligible at Investigator's discretion.
  • Living in a home that has been renovated in the past 4-weeks.
Show all 11Show fewer
  • Have known severe food allergies or anaphylaxis to common food allergens. As per the Investigator's discretion.
  • Not suitable for the study for any other reason, as determined by the investigator.
  • Acute infection, surgery, vaccination, or other inflammatory process in the previous 2 weeks. Minor procedures are exempt at investigator's discretion.
  • Evidence of moderate or greater renal impairment at screening, as indicated by an estimated creatinine clearance of less than 60 mL/min using the Cockcroft-Gault equation.
  • Clinically significant abnormal laboratory tests or examination findings, as determined by the investigator, not otherwise mentioned.

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Harry Perkins Institute of Medical Research

    Nedlands, Western Australia, 6009

Other trials in Australia

About this study

Official title: Examining the Effect of Minimal Plastics Exposure on Plastic-Associated Chemicals (PAC) Excretion and Biomarkers in Adults With Cardiometabolic Risk Factors

The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. The main questions it aims to answer are:

  • Will the low plastic exposure intervention reduce urinary excretion of bisphenols?
  • Will the low plastic exposure intervention reduce urinary excretion of phthalate metabolites?
  • Can reducing plastic exposure improve cardiometabolic biomarkers?
Read more

Researchers will compare this 4-week low plastic intervention with a control/no intervention group.

Participants in the intervention group will:

  • be provided with food that have no/low plastic and plastic-associated chemicals
  • be provided with personal care and cleaning produces that have no/low plastic and plastic-associated chemicals
  • replace cooking and food preparation equipment with no/low plastic alternatives

Participants in the control group will not receive the intervention and are not expected to change their behaviour.

All participants will provide biological samples (urine, stool, nasal lavage and blood) at several timepoints during the study and attend 4 clinic visits: screening and before, during and after the intervention. Participants will also complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.

Read the detailed description

Many plastic products contain endocrine disrupting chemicals, such as bisphenols and phthalates (referred to as plastic-associated chemicals or PAC), which leach out from everyday use and enter the human body. Food contaminated from packaging or with plastic particles, personal care and cleaning products may be sources of PAC which can be inhaled or absorbed through the skin. The fundamental premise underpinning the research is that exposure to PAC, combined with genetic and lifestyle factors, creates chronic and systemic inflammation that underpins cardiometabolic conditions.

This randomized controlled trial aims to demonstrate whether decreasing exposure to plastic and PAC will reduce urinary excretion of PAC and improve cardiometabolic biomarkers in people with cardiometabolic risk factors.

Participants that have consented and passed health screening (N=60) will be randomized to one of two parallel groups, to receive a 4-week low plastic intervention in their homes with the support of registered dietitians.

  • Group 1 (N=30): low plastic intervention group
  • Group 2 (N=30): control/no intervention group

All participants will attend four in-person clinic appointments, one during screening, and three during the intervention (Visit 1: day 0, baseline; Visit 2: day 16, midpoint; and Visit 3: day 29, post intervention), of up to two hours duration each. In addition, participants will have a video/phone appointment between screening and Visit 1.

The day before and after the video/phone appointment, participants will be asked to collect urine, stool and nasal washing samples and send them back the day after their video/phone appointment. At the end of the video/phone appointment, eligible and willing participants will be invited to continue to the intervention study and randomized into either the intervention or control group. At the video/phone appointment, participants from Group 1 will order their food and personal care products. The researchers will send the order to a local meal service delivery who will order, pay for, package, and deliver the approved food to the participants' homes in insulated boxes. Delivery of approved products to participants' homes will take place the day before the intervention begins, and at other pre-determined timepoints throughout the study, as required. Samples of food products will be frozen for retrospective testing for PAC, if exposure testing indicates contamination from an unexpected source. Participants from Group 1 will use only non-plastic cooking utensils provided by the researchers and follow guidance concerning the preparation of their food. Participants from Group 1 will use only personal care and cleaning products supplied by the research team. Personal care products include, but are not limited to shampoo, conditioners, face moisturizers, cleansers, serums, make-up and sunscreens, deodorant, tampons and applicators. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention.

All participants will be asked to collect urine, stool, and nasal washing samples on days -1, 8, 15, 22 and 28 of the intervention period, and return them at the clinic visits. During the clinic visits, participants will have fasting blood sample taken, complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall - plastic exposure (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.

For intervention adherence the following assessment tools will be employed:

24-hour dietary recall - plastic exposure interview (24DR-PE): This assessment is a researcher-administered, computer-assisted, 24-hour dietary recall interview. The method assesses dietary intake on the preceding 24-hour period. The method is adapted to gather additional information concerning the packaging, storage, and preparation of food by the participants. Trained dietitians will carry out the interviews during the clinic visits. The interviews will vary in length between 15 and 60 minutes depending on the stage of the study, and the complexity of each participants' diet. They will be carried out once during screening and three times during the 4-week intervention.

24-hour personal care product recall (24HR-PPR): This is a self-administered questionnaire for the 24-hour recall of personal care products use. This assessment will be conducted once during screening and three times during the 4-week intervention. The questionnaire consists of 15 questions and will take between 2 and 5 minutes to complete.

Post-trial survey: This survey will be conducted to identify any difficulties experienced by the participants that might have affected their adherence to the intervention and procedures.

Tolerability and feasibility qualitative interview: To evaluate the tolerability and feasibility of the trial intervention, participants will be invited to participate in a phone interview within two weeks of completing the intervention. A trained interviewer will conduct the interviews using a structured guide that includes both closed and open-ended questions. Each interview is expected to last 20-40 minutes.

Being tested
Low Plastic Intervention
Keywords
Plastic, Microplastic, Nanoplastic, Plastic associated chemicals, Bisphenols, Phthalates, Inflammation
Medical subject headings
Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low Plastic InterventionBehavioural

    Participants will be provided with food that contain no or low plastic and PAC. This is defined as minimally processed (according to NOVA Classification) fresh produce where the supply chain is either known to be free, or likely to be free of plastic contamination. Foods that are canned, pickled, use plastic storage containers will be either avoided or substituted where possible with glass. Participants will also follow guidance concerning the preparation of their food. Plastic utensils used in the preparation of food will be substituted for non-plastic. Commonly used personal care products, e.g., shampoo and soaps, and cleaning products will be replaced with no/low PAC alternatives. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention.

Study groups in NCT06571994
Study groupRoleWhat they receive
Low Plastic Intervention GroupExperimental30 participants randomly assigned to the intervention group will consume low PAC food, employ low risk PAC food preparation practices, and use low PAC personal care and cleaning products.
Receives: Behavioral: Low Plastic Intervention
Control GroupNo intervention30 participants randomly assigned to the control group will not receive the intervention nor expected to change behaviour.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in bisphenols (composite of bisphenol A, BPA; and bisphenol S, BPS)

    Assessed by measuring urinary concentrations (ng/mL) of BPA and BPS and comparing mean percent change

    Measured: Baseline and 4 weeks for both groups

Secondary outcomes (7)
  1. Change in bisphenol A (BPA)

    Assessed by measuring urinary concentrations BPA (ng/mL) and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  2. Change in bisphenol S (BPS)

    Assessed by measuring urinary concentrations of BPS (ng/mL) and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  3. Change in diethyl phthalate (DEP)

    Assessed by measuring urinary concentrations (ng/mL) of DEP metabolite, mono-ethyl phthalate (MEP), and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  4. Change in di-n-butyl-phthalate (DnBP)

    Assessed by measuring urinary concentrations (ng/mL) of DnBP metabolites, mono-n-butyl-phthalate (MnBP) and mono-(3-carboxypropyl) phthalate (MCPP), and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  5. Change in di-iso-butyl phthalate (DiBP)

    Assessed by measuring urinary concentrations (ng/mL) of DiBP metabolite, mono-iso-butyl phthalate (MiBP), and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  6. Change in benzyl butyl phthalate (BBP)

    Assessed by measuring urinary concentrations (ng/mL) of BBP metabolite, mono-benzyl phthalate (MBzP), and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

  7. Change in di-(2-ethylhexyl) phthalate (DEHP)

    Assessed by measuring urinary concentrations (ng/mL) of the composite of DEHP metabolites (mono-2-ethylhexyl phthalate, MEHP; mono-(2-ethyl-5-oxohexyl) phthalate, MEOHP; mono-(2-ethyl-5-hydroxyhexyl) phthalate, MEHHP; and mono-(2-ethyl-5-carboxypentyl) phthalate, MECPP) and compare mean percent change

    Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2024
  2. Study start5 Sep 2024
  3. Primary completion3 Jul 2025
  4. Study completion4 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06571994
Sponsor's protocol ID
2021_ET001118
Acronym
PERTH
Status last verified
Dec 2025
First submitted
31 Jul 2024
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: At this stage of the study the investigators do not plan to share IPD but this decision may be reviewed in the future.

Publications

  • Lucas A, Harray A, Duong L, Herrmann S, Vlaskovsky P, Trevenen M, Chan D, Papendorf H, Smith T, Flint L, Liu A, Gaudieri S, Wang X, Mueller JF, Thomas KV, Murray K, Symeonides C, Dunlop S, Watts G, Lucas M. Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial - a protocol. BMJ Open. 2025 Aug 25;15(8):e099330. doi: 10.1136/bmjopen-2025-099330.

    PubMed 40854835

Questions about this trial

What is this clinical trial studying?

A study testing Low Plastic Intervention in people with Endocrine Disruptors and Inflammation, run by The University of Western Australia at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in bisphenols (composite of bisphenol A, BPA; and bisphenol S, BPS) (time frame: Baseline and 4 weeks for both groups). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06571994, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in